A new Zetasizer era.
In this launch event, we will unveil the newest innovation in the Zetasizer product family introducing a breakthrough approach designed for complete stability characterization at scale.
See how consistent, reproducible and scalable data can give you the information to take high-stakes decisions with confidence.
Join us to discover how you can:
- Accelerate screening with high-throughput sample analysis
- Assess thermal stability earlier and more reliably in lead selection
- Streamline B22 measurements with fast, high-quality assays
- Reduce screening costs without compromising data quality
발표자
- Agatha Rosenthal - Market Development Manager Biologics, Malvern Panalytical
- John Stenson - Product Manager, Malvern Panalytical
자세한 내용
Who should attend?
- Researchers in protein science
- Scientists in protein formulation/ analytical development/ biophysics/ QC
- Anyone interested in protein characterization and stability, and analytical instrumentation
What will you learn?
Join us to discover the new analytical platform to help accelerate your biologics pipeline, reduce cost per data point and bridge the gap from Drug Discovery to Quality Control.